UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Changes in circulating microRNA levels associated with prostate cancer

British journal of cancer, 2012-02, Vol.106 (4), p.768-774

2012

Volltextzugriff (PDF)

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair

British journal of cancer, 2013-03, Vol.108 (4), p.748-754

2013

Volltextzugriff (PDF)

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer

British journal of cancer, 2012-06, Vol.107 (1), p.123-128

2012

Volltextzugriff (PDF)

Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers

Histopathology, 2005-03, Vol.46 (3), p.256-269

2005

Volltextzugriff (PDF)

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial

BMC cancer, 2020-10, Vol.20 (1), p.971-971, Article 971

2020

Volltextzugriff (PDF)

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result

British journal of cancer, 2010-04, Vol.102 (9), p.1335-1340

2010

Volltextzugriff (PDF)

EZH2 promotes proliferation and invasiveness of prostate cancer cells

The Prostate, 2007-04, Vol.67 (5), p.547-556

2007

Volltextzugriff (PDF)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls

Oncogene, 2006-03, Vol.25 (13), p.1984-1988

2006

Volltextzugriff (PDF)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma

The Journal of pathology, 2006-07, Vol.209 (3), p.336-343

2006

Volltextzugriff (PDF)

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

British journal of cancer, 2014-06, Vol.110 (12), p.2829-2836

2014

Volltextzugriff (PDF)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: A pilot study

Urology (Ridgewood, N.J.), 2004-12, Vol.64 (6), p.1238-1243

2004

Volltextzugriff (PDF)

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer

Oncogene, 2006-05, Vol.25 (20), p.2953-2960

2006

Volltextzugriff (PDF)

Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer

British journal of cancer, 2017-01, Vol.116 (2), p.227-236

2017

Volltextzugriff (PDF)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study

BMJ, 2012-01, Vol.344 (jan09 1), p.d7894-d7894

International edition, 2012

Volltextzugriff (PDF)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study

British journal of cancer, 2011-03, Vol.104 (5), p.875-881

2011

Volltextzugriff (PDF)

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype

The Journal of pathology, 2008-02, Vol.214 (3), p.394-404

2008

Volltextzugriff (PDF)

The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells

The Prostate, 2008-02, Vol.68 (3), p.255-263

2008

Volltextzugriff (PDF)

Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies

European journal of cancer (1990), 2010-11, Vol.46 (17), p.3095-3101

2010

Volltextzugriff (PDF)

FGF8 isoform b expression in human prostate cancer

British journal of cancer, 2003-05, Vol.88 (9), p.1432-1438

2003

Volltextzugriff (PDF)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study

British journal of cancer, 2011-09, Vol.105 (7), p.931-937

2011

Volltextzugriff (PDF)

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project

European urology, 2005-12, Vol.48 (6), p.1031-1041

2005

Volltextzugriff (PDF)

Prostate specific antigen: biology, biochemistry and available commercial assays

Annals of clinical biochemistry, 2001-11, Vol.38 (Pt 6), p.633-651

2001

Volltextzugriff (PDF)

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes

Annals of oncology, 2015-04, Vol.26 (4), p.756-761

2015

Volltextzugriff (PDF)

Behavior of Urothelial Carcinoma With Respect to Anatomical Location

The Journal of urology, 2007-05, Vol.177 (5), p.1715-1720

2007

Volltextzugriff (PDF)

Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men

British journal of cancer, 2003-06, Vol.88 (11), p.1682-1686

2003

Volltextzugriff (PDF)

1 – 25 von 555

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(476)
Mit Volltextzugriff
(450)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Changes in circulating microRNA levels associated with prostate cancer

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer

Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result

EZH2 promotes proliferation and invasiveness of prostate cancer cells

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: A pilot study

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer

Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study

BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype

The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells

Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies

FGF8 isoform b expression in human prostate cancer

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project

Prostate specific antigen: biology, biochemistry and available commercial assays

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes

Behavior of Urothelial Carcinoma With Respect to Anatomical Location

Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men

Suchergebnisse filtern